SLNCF — Silence Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Silence Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	33.5	37.4	73.5	71.1	54
Net Total Accounts Receivable
Net Total Receivables	3.52	33.5	8.49	17.3	18.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets	37.5	76.4	86.3	96.7	81
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.611	1.13	1.94	2.2	1.81
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	46.1	86	96.2	108	93.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.65	25.6	15.2	21.7	17.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	25.2	76.9	87.7	85.4	76.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	20.9	9.06	8.53	22.1	17.1
Total Liabilities & Shareholders' Equity	46.1	86	96.2	108	93.8
Total Common Shares Outstanding